UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
26.75
-0.10 (-0.37%)
Jun 8, 2026, 10:42 AM EDT - Market open
UroGen Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +68.22% | Jun 3, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $40 | Buy | Reiterates | $40 | +49.53% | May 19, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $18 | Hold | Maintains | $18 | -32.71% | May 18, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +30.84% | May 15, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $43 | Buy | Initiates | $43 | +60.75% | May 11, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $32 | Buy | Maintains | $32 | +19.63% | May 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 | Buy | Maintains | $40 | +49.53% | Apr 20, 2026 |
| Jefferies | Jefferies | Buy Initiates $40 | Buy | Initiates | $40 | +49.53% | Apr 9, 2026 |